` 9996 (Peijia Medical Ltd) vs Hang Seng (Hong Kong) Comparison - Alpha Spread

P
9996
vs
H
Hang Seng (Hong Kong)

Over the past 12 months, Peijia Medical Ltd has outperformed Hang Seng (Hong Kong), delivering a return of +46% compared to the Hang Seng (Hong Kong)'s +29% growth.

Stocks Performance
9996 vs Hang Seng (Hong Kong)

Loading
9996
Hang Seng (Hong Kong)
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
9996 vs Hang Seng (Hong Kong)

Loading
9996
Hang Seng (Hong Kong)
Difference
www.alphaspread.com

Performance By Year
9996 vs Hang Seng (Hong Kong)

Loading
9996
Hang Seng (Hong Kong)
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Peijia Medical Ltd vs Peers

Hang Seng (Hong Kong)
9996
ABT
ISRG
BSX
SYK
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Peijia Medical Ltd
Glance View

Market Cap
3.9B HKD
Industry
Health Care

Peijia Medical Ltd. engages in the manufacture and sale of medical devices. The company is headquartered in Suzhou, Jiangsu. The company went IPO on 2020-05-15. Through its subsidiaries, the Company operates two segments. Transcatheter Valve Therapeutic Business segment is mainly engaged in the development of transcatheter valve therapeutic medical devices. Neurointerventional Business segment is engaged in the research and development of neurointerventional procedural medical devices. The firm's main products under development include TaurusOne, TaurusElite, TaurusNXT and others. The firm operates its businesses primarily in domestic market.

Intrinsic Value
9.5 HKD
Undervaluation 40%
Intrinsic Value
Price
P
Back to Top